magnolol has been researched along with Benign Neoplasms, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Cheng, YC; Chiu, CY; Kan, PC; Tsao, MJ | 1 |
| Chen, JY; Chen, Y; Cheng, YC; Huang, HY; Hueng, DY | 1 |
2 other study(ies) available for magnolol and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Magnolol Inhibits Human Glioblastoma Cell Migration by Regulating N-Cadherin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Brain Neoplasms; Cadherins; Cell Line, Tumor; Cell Movement; Cell Survival; Glioblastoma; Humans; Lignans; Mice; Mice, Inbred BALB C; Myosin-Light-Chain Kinase; Neoplasm Transplantation; Phosphorylation; Wound Healing | 2018 |
Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Biphenyl Compounds; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Glioblastoma; Humans; Lignans; Mice; Mice, Nude; Xenograft Model Antitumor Assays | 2016 |